Yüklüyor......
Recombinant Immunotoxin with T Cell Epitope Mutations that Greatly Reduce Immunogenicity for Treatment of Mesothelin Expressing Tumors
SS1P is a recombinant immunotoxin (RIT) that targets mesothelin. It consists of an anti-mesothelin Fv fused to a portion of Pseudomonas exotoxin A. In clinical studies it has produced dramatic responses in patients with advanced mesothelioma, when combined with immunosuppressive therapy so that seve...
Kaydedildi:
| Yayımlandı: | Mol Cancer Ther |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674367/ https://ncbi.nlm.nih.gov/pubmed/26443804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0532 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|